The FDA is yet to approve Paxlovid, a COVID-19 pill
Paxlovid antiviral medication is being developed by Pfizer and MPP for low- and middle-income countries.
Paxlovid antiviral medication is being developed by Pfizer and MPP for low- and middle-income countries.